Average Co-Inventor Count = 7.25
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (30 from 290 patents)
30 patents:
1. 10947264 - Process for preparation of sulfonylurea bile acid derivatives
2. 10584145 - Process for preparation of sulfonylurea bile acid derivatives
3. 10364267 - Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
4. 9526769 - Macrocylic oximyl hepatitis C protease inhibitors
5. 9242974 - Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
6. 8962551 - Quinoxalinyl derivatives
7. 8927739 - Processes for the preparation of 5-azaspiro[2.4]heptane-6-carboxylic acid and its derivatives
8. 8921573 - Processes for the preparation of novel benzimidazole derivatives
9. 8809264 - Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors
10. 8552162 - Processes for the preparation of 2 fluoro 6-11 bicyclic erythromycin derivatives
11. 8501681 - Macrocyclic hepatitis C virus serine protease inhibitors
12. 8268776 - Macrocylic oximyl hepatitis C protease inhibitors
13. 8268777 - Oximyl macrocyclic derivatives
14. 8236807 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
15. 8193346 - Process for making macrocyclic oximyl hepatitis C protease inhibitors